A novel mechanism for regulating hepatic glycogen synthesis involving serotonin and cyclin-dependent kinase-5

Diabetes

Volumn 61, Issue 1, 2012, Pages 49-60

  Tudhope, Susan J ^a   Wang, Chung Chi ^a   Petrie, John L ^a   Potts, Lloyd ^a   Malcomson, Fiona ^a   Kieswich, Julius ^b   Yaqoob, Muhammad M ^b   Arden, Catherine ^a   Hampson, Laura J ^a   Agius, Loranne ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; GLUCOSE; GLYCOGEN PHOSPHORYLASE; INSULIN; NORADRENALIN; OLANZAPINE; PHOSPHORYLASE PHOSPHATASE; PROTEIN P35; ROSCOVITINE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1 RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; GLYCOLYSIS; LIVER CELL; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; HEPATOCYTES; INDOLES; LIVER; LIVER GLYCOGEN; MALE; METABOLIC NETWORKS AND PATHWAYS; PYRIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; TETRAHYDRONAPHTHALENES;

EID: 84555177974     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0870     Document Type: Article

References (50)

1. DeFronzo RA, Ferrannini E, Hendler R, Wahren J, Felig P. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci USA 1978;75:5173-5177 (Pubitemid 9046504)
2. Bergman RN, Beir JR, Hourigan PM. Intraportal glucose infusion matched to oral glucose absorption. Lack of evidence for "gut factor" involvement in hepatic glucose storage. Diabetes 1982;31:27-35 (Pubitemid 12254628)
3. Pagliassotti MJ, Cherrington AD. Regulation of net hepatic glucose uptake in vivo. Annu Rev Physiol 1992;54:847-860
4. Cherrington AD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999;48:1198-1214 (Pubitemid 29226371)
5. Adkins-Marshall B, Pagliassotti MJ, Asher JR, et al. Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am J Physiol 1992;262:E679-E686
6. Niijima A. Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. J Physiol 1982;332:315-323 (Pubitemid 13253455)
7. Shimazu T. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 1981;20(Suppl.):343-356 (Pubitemid 11159668)
8. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998;336:19-31 (Pubitemid 28532556)
9. Püschel GP. Control of hepatocyte metabolism by sympathetic and parasympathetic hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol 2004; 280:854-867 (Pubitemid 39330965)
10. Jungermann K, Gardemann A, Beuers U, et al. Regulation of liver metabolism by the hepatic nerves. Adv Enzyme Regul 1987;26:63-88
11. Mondon CE, Burton SD. Factors modifying carbohydrate metabolism and effect of insulin in perfused rat liver. Am J Physiol 1971;220:724-734
12. Ottolenghi C, Cania A, Barnabei O. Effect of acetylcholine on glycogen formation and the activity of glycogen synthetase in isolated, perfused rat liver. Nature 1971;229:420-422
13. Gardemann A, Beck H, Jungermann K. Differential control of glycogenolysis and flow by arterial and portal acetylcholine in perfused rat liver. Biochem J 1990;271:599-604 (Pubitemid 20384589)
14. Hampson LJ, Agius L. Acetylcholine exerts additive and permissive but not synergistic effects with insulin on glycogen synthesis in hepatocytes. FEBS Lett 2007;581:3955-3960 (Pubitemid 47212101)
15. el-Salhy M, Stenling R, Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993;28:809-815 (Pubitemid 23274891)
16. Lam DD, Heisler LK. Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert Rev Mol Med 2007;9:1-24 (Pubitemid 46358401)
17. Moore MC, Geho WB, Lautz M, Farmer B, Neal DW, Cherrington AD. Portal serotonin infusion and glucose disposal in conscious dogs. Diabetes 2004;53:14-20 (Pubitemid 38044692)
18. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008;195:198-213
19. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-107
20. Hampson LJ, Mackin P, Agius L. Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs. Diabetologia 2007;50:1743-1751 (Pubitemid 47036645)
21. Starrenburg FC, Bogers JP. How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry 2009;24:164-170
22. Derijks HJ, Meyboom RH, Heerdink ER, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol 2008;64:531-538
23. Chan TM, Exton JH. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 1976;71:96-105
24. Aiston S, Hampson L, Gómez-Foix AM, Guinovart JJ, Agius L. Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis. J Biol Chem 2001;276:23858-23866
25. Wilson WA, Wang Z, Roach PJ. Regulation of yeast glycogen phosphorylase by the cyclin-dependent protein kinase Pho85p. Biochem Biophys Res Commun 2005;329:161-167 (Pubitemid 40255435)
26. Payne VA, Arden C,Wu C, Lange AJ, Agius L. Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes. Diabetes 2005;54:1949-1957 (Pubitemid 40911256)
27. Gomis RR, Favre C, García-Rocha M, Fernández-Novell JM, Ferrer JC, Guinovart JJ. Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase. J Biol Chem 2003;278:9740-9746 (Pubitemid 36800472)
28. Hajduch E, Rencurel F, Balendran A, Batty IH, Downes CP, Hundal HS. Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 1999;274:13563-13568
29. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-554 (Pubitemid 34219205)
30. Ismaiel AM, Titeler M, Miller KJ, Smith TS, Glennon RA. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin. J Med Chem 1990;33:755-758 (Pubitemid 20047604)
31. Zhang W, Bymaster FP. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology (Berl) 1999;141:267-278 (Pubitemid 29196076)
32. Audinot V, Newman-Tancredi A, Cussac D, Millan MJ. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors. Neuropsychopharmacology 2001;25:410-422 (Pubitemid 32780547)
33. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18
34. Agius L. Physiological control of liver glycogen metabolism: lessons from novel glycogen phosphorylase inhibitors. Mini Rev Med Chem 2010;10:1175-1187
35. Härndahl L, Schmoll D, Herling AW, Agius L. The role of glucose 6-phosphate in mediating the effects of glucokinase overexpression on hepatic glucose metabolism. FEBS J 2006;273:336-346
36. Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007;408:297-315
37. Lalioti V, Pulido D, Sandoval IV. Cdk5, the multifunctional surveyor. Cell Cycle 2010;9:284-311
38. Van Schaftingen E. Involvement of phosphorylase kinase inhibition in the effect of resorcinol and proglycosyn on glycogen metabolism in the liver. Eur J Biochem 1995;234:301-307
39. Ubeda M, Kemp DM, Habener JF. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells. Endocrinology 2004;145:3023-3031 (Pubitemid 38686252)
40. Li T, Chalifour LE, Paudel HK. Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. J Biol Chem 2007;282:6619-6628 (Pubitemid 47100889)
41. Pagliassotti MJ, Holste LC, Moore MC, Neal DW, Cherrington AD. Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest 1996;97:81-91 (Pubitemid 26021697)
42. Nakamura T, Tomomura A, Kato S, Noda C, Ichihara A. Reciprocal expressions of alpha 1- and beta-adrenergic receptors, but constant expression of glucagon receptor by rat hepatocytes during development and primary culture. J Biochem 1984;96:127-136 (Pubitemid 14089273)
43. Kajiyama Y, Ui M. Switching from alpha 1- to beta-subtypes in adrenergic response during primary culture of adult-rat hepatocytes as affected by the cell-to-cell interaction through plasma membranes. Biochem J 1994;303:313-321
44. Bollen M, Peti W, Ragusa MJ, Beullens M. The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci 2010;35:450-458
45. Perry JR, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 2008;11:371-377
46. Aggen JB, Nairn AC, Chamberlin R. Regulation of protein phosphatase-1. Chem Biol 2000;7:R13-R23 (Pubitemid 30141918)
47. Schnack C, Hengerer B, Gillardon F. Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 2008;8:1980-1986 (Pubitemid 351775778)
48. Liu F, Ma XH, Ule J, et al. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc Natl Acad Sci USA 2001;98:11062-11068 (Pubitemid 32928683)
49. Benavides DR, Bibb JA. Role of Cdk5 in drug abuse and plasticity. Ann N Y Acad Sci 2004;1025:335-344 (Pubitemid 39643879)
50. Dicostanzo CA, Dardevet DP, Neal DW, et al. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal. Am J Physiol Endocrinol Metab 2006;290:E9-E16